Download PDF
Semin Hear 2012; 33(03): 251-260
DOI: 10.1055/s-0032-1315724
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Sudden Sensorineural Hearing Loss Due to Drug Abuse

Ivan A. Lopez
1   Department of Head and Neck Surgery
,
Akira Ishiyama
1   Department of Head and Neck Surgery
,
Gail Ishiyama
2   Department of Neurology, “David Geffen” School of Medicine at UCLA, Los Angeles, California
› Author Affiliations
Further Information

Publication History

Publication Date:
31 July 2012 (online)

   Permissions and Reprints

Abstract

In the last 10 years, there has been an emergence of reports related to opioid-induced sudden sensorineural hearing loss (SSNHL). The underlying pathology is not completely understood, and the mechanism(s) of action of these drugs in the inner ear remains to be determined. Reports of SSNHL due to the abuse of opioid peptides and other drugs suggest that the opioid system in the inner ear is affected. The reversible or irreversible effect on auditory function depends on the type of drug used and several other factors, including duration and time of exposure as well as the health status of drug users. Abuse of hydrocodone + acetaminophen (Vicodin® hydrocodone/paracetamol; Abbott Laboratories, Worcester, MA) has induced permanent hearing loss in several individuals. In contrast, abuse of heroin-induced hearing loss that was sometimes reversible. The widespread expression and physiological action of endogenous peptide opioids and their receptors in the inner ear suggests that pharmacological treatment for drug-induced hearing loss is possible. The present study reviews the basic concepts of opioids and their receptors, provides clinical examples of hearing loss mediated by opioids and related drugs, reviews experimental evidence of the presence of opioids and their receptors in the inner ear (animal models and human studies), and describes the cellular targets affected by opioids and other recreational drugs.

Keywords

Human cochlea - opioids receptors - hydrocodone - heroin - hearing loss
 

  • References

  • 1 Bie B, Pan ZZ. Trafficking of central opioid receptors and descending pain inhibition. Mol Pain 2007; 3: 27
    CrossrefPubMedGoogle Scholar
  • 2 Zuo Z. The role of opioid receptor internalization and b-arrestins in the development of opioid tolerance. Anesth Analg 2005; 10: 728-734
    PubMedGoogle Scholar
  • 3 Meyer MR, Maurer HH. Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse. Pharmacogenomics 2011; 12: 215-233
    CrossrefPubMedGoogle Scholar
  • 4 Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician 2008; 11: S133-153
    PubMedGoogle Scholar
  • 5 Ho T, Vrabec JT, Burton AW. Hydrocodone use and sensorineural hearing loss. Pain Physician 2007; 10: 467-472
    PubMedGoogle Scholar
  • 6 National Institute on Drug Abuse. Prescription Drugs: Abuse and Addiction. U.S. Department of Health and Human Services, National Institutes of Health/National Institute on Drug Abuse, Baltimore, MD. NIH Publication number 11–4881, 2011
    PubMedGoogle Scholar
  • 7 Trigo JM, Martin-García E, Berrendero F, Robledo P, Maldonado R. The endogenous opioid system: a common substrate in drug addiction. Drug Alcohol Depend 2010; 108: 183-194
    CrossrefPubMedGoogle Scholar
  • 8 Schweitzer VG, Darrat I, Stach BA, Gray E. Sudden bilateral sensorineural hearing loss following polysubstance narcotic overdose. J Am Acad Audiol 2011; 22: 208-214
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Waldhoer M, Bartlett SE, Whistler JL. Opioid receptors. Annu Rev Biochem 2004; 73: 953-990
    CrossrefPubMedGoogle Scholar
  • 10 Slepecky N. Structure of the mammalian cochlea. In: Dallos P, Popper AN, Fay RR, eds. The Cochlea. Springer Handbook of Auditory Research. New York, NY: Springer; 1996: 44-129
    CrossrefGoogle Scholar
  • 11 Defourny J, Lallemend F, Malgrange B. Structure and development of cochlear afferent innervations in mammals. Am J Physiol Cell Physiol 2011; 301: C750-C761
    CrossrefPubMedGoogle Scholar
  • 12 Guinan Jr JJ. Cochlear efferent innervation and function. Curr Opin Otolaryngol Head Neck Surg 2010; 18: 447-453
    CrossrefPubMedGoogle Scholar
  • 13 Schrott-Fischer A, Kammen-Jolly K, Scholtz A, Rask-Andersen H, Glueckert R, Eybalin M. Efferent neurotransmitters in the human cochlea and vestibule. Acta Otolaryngol 2007; 127: 13-19
    PubMedGoogle Scholar
  • 14 Elgoyhen AB, Katz E. The efferent medial olivocochlear-hair cell synapse. J Physiol Paris 2011; ; July 6 (Epub ahead of print)
    PubMedGoogle Scholar
  • 15 Halmos G, Doleviczényi Z, Répássy G , et al. D2 autoreceptor inhibition reveals oxygen-glucose deprivation-induced release of dopamine in guinea-pig cochlea. Neuroscience 2005; 132: 801-809
    CrossrefPubMedGoogle Scholar
  • 16 Lyon MJ, Payman RN. Comparison of the vascular innervation of the rat cochlea and vestibular system. Hear Res 2000; 141: 189-198
    CrossrefPubMedGoogle Scholar
  • 17 Scherer EQ, Arnold W, Wangemann P. Pharmacological reversal of endothelin-1 mediated constriction of the spiral modiolar artery: a potential new treatment for sudden sensorineural hearing loss. BMC Ear Nose Throat Disord 2005; 5: 10
    CrossrefPubMedGoogle Scholar
  • 18 Maison SF, Le M, Larsen E , et al. Mice lacking adrenergic signaling have normal cochlear responses and normal resistance to acoustic injury but enhanced susceptibility to middle-ear infection. J Assoc Res Otolaryngol 2010; 11: 449-461
    PubMedGoogle Scholar
  • 19 Wangemann P, Wonneberger K. Neurogenic regulation of cochlear blood flow occurs along the basilar artery, the anterior inferior cerebellar artery and at branch points of the spiral modiolar artery. Hear Res 2005; 209: 91-96
    CrossrefPubMedGoogle Scholar
  • 20 Guinan Jr JJ. Olivocochlear efferents: anatomy, physiology, function, and the measurement of efferent effects in humans. Ear Hear 2006; 27: 589-607
    PubMedGoogle Scholar
  • 21 Puel JL. Chemical synaptic transmission in the cochlea. Prog Neurobiol 1995; 47: 449-476
    CrossrefPubMedGoogle Scholar
  • 22 Usami SI, Takumi Y, Matsubara A, Fujita S, Ottersen OP. Neurotransmission in the vestibular endorgans—glutamatergic transmission in the afferent synapses of hair cells. Biol Sci Space 2001; 15: 367-370
    CrossrefPubMedGoogle Scholar
  • 23 Hakuba N, Koga K, Gyo K, Usami SI, Tanaka K. Exacerbation of noise-induced hearing loss in mice lacking the glutamate transporter GLAST. J Neurosci 2000; 20: 8750-8753
    PubMedGoogle Scholar
  • 24 Darrow KN, Simons EJ, Dodds L, Liberman MC. Dopaminergic innervation of the mouse inner ear: evidence for a separate cytochemical group of cochlear efferent fibers. J Comp Neurol 2006; 498: 403-414
    CrossrefPubMedGoogle Scholar
  • 25 Lendvai B, Halmos GB, Polony G , et al. Chemical neuroprotection in the cochlea: the modulation of dopamine release from lateral olivocochlear efferents. Neurochem Int 2011; 59: 150-158
    CrossrefPubMedGoogle Scholar
  • 26 Ross S, Peselow E. Pharmacotherapy of addictive disorders. Clin Neuropharmacol 2009; 32: 277-289
    CrossrefPubMedGoogle Scholar
  • 27 Williams JT, Christie MJ, Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 2001; 81: 299-343
    PubMedGoogle Scholar
  • 28 Fex J, Altschuler RA. Enkephalin-like immunoreactivity of olivocochlear nerve fibers in cochlea of guinea pig and cat. Proc Natl Acad Sci U S A 1981; 78: 1255-1259
    CrossrefPubMedGoogle Scholar
  • 29 Hoffman DW, Altschuler RA, Fex J. High-performance liquid chromatographic identification of enkephalin-like peptides in the cochlea. Hear Res 1983; 9: 71-78
    CrossrefPubMedGoogle Scholar
  • 30 Eybalin M. Neurotransmitters and neuromodulators of the mammalian cochlea. Physiol Rev 1993; 73: 309-373
    PubMedGoogle Scholar
  • 31 Phansuwan-Pujito P, Saleema L, Mukda S , et al. The opioid receptors in inner ear of different stages of postnatal rats. Hear Res 2003; 184: 1-10
    CrossrefPubMedGoogle Scholar
  • 32 Jongkamonwiwat N, Phansuwan-Pujito P, Sarapoke P , et al. The presence of opioid receptors in rat inner ear. Hear Res 2003; 181: 85-93
    CrossrefPubMedGoogle Scholar
  • 33 Jongkamonwiwat N, Phansuwan-Pujito P, Casalotti SO, Forge A, Dodson H, Govitrapong P. The existence of opioid receptors in the cochlea of guinea pigs. Eur J Neurosci 2006; 23: 2701-2711
    CrossrefPubMedGoogle Scholar
  • 34 Popper P, Cristobal R, Wackym PA. Expression and distribution of mu opioid receptors in the inner ear of the rat. Neuroscience 2004; 129: 225-233
    CrossrefPubMedGoogle Scholar
  • 35 Kho ST, Lopez IA, Evans C, Ishiyama A, Ishiyama G. Immunolocalization of orphanin FQ in rat cochlea. Brain Res 2006; 1113: 146-152
    CrossrefPubMedGoogle Scholar
  • 36 Ishiyama G, Lopez IA, Ishiyama A, Evans CJ. Immunolocalization of mu and delta opioid receptors in the mouse cochlea. Paper presented at: 26th ARO Meeting, Daytona Beach, FL, Feb. 22–37. Abstract # 1850; 2003
    PubMedGoogle Scholar
  • 37 Sahley TL, Kalish RB, Musiek FE, Hoffman DW. Effects of opioid be drugs on auditory evoked potentials suggest a role of lateral olivocochlear dynorphins in auditory function. Hear Res 1991; 55: 133-142
    CrossrefPubMedGoogle Scholar
  • 38 Eybalin M, Pujol R, Bockaert J. Opioid receptors inhibit the adenylate cyclase in guinea pig cochleas. Brain Res 1987; 421: 336-342
    CrossrefPubMedGoogle Scholar
  • 39 Vega R, Soto E. Opioid receptors mediate a postsynaptic facilitation and a presynaptic inhibition at the afferent synapse of axolotl vestibular hair cells. Neuroscience 2003; 118: 75-85
    CrossrefPubMedGoogle Scholar
  • 40 Lioudyno MI, Verbitsky M, Glowatzki E , et al. The alpha9/alpha10-containing nicotinic ACh receptor is directly modulated by opioid peptides, endomorphin-1, and dynorphin B, proposed efferent cotransmitters in the inner ear. Mol Cell Neurosci 2002; 20: 695-711
    CrossrefPubMedGoogle Scholar
  • 41 Soto E, Vega R. Neuropharmacology of vestibular system disorders. Curr Neuropharmacol 2010; 8: 26-40
    CrossrefPubMedGoogle Scholar
  • 42 Ho T, Vrabec JT, Burton AW. Hydrocodone use and sensorineural hearing loss. Pain Physician 2007; 10: 467-472
    PubMedGoogle Scholar
  • 43 Oh AK, Ishiyama A, Baloh RW. Deafness associated with abuse of hydrocodone/acetaminophen. Neurology 2000; 54: 2345
    CrossrefPubMedGoogle Scholar
  • 44 Friedman RA, House JW, Luxford WM, Gherini S, Mills D. Profound hearing loss associated with hydrocodone/acetaminophen abuse. Am J Otol 2000; 21: 188-191
    CrossrefPubMedGoogle Scholar
  • 45 Rigby MH, Parnes LS. Profound hearing loss associated with oxycodone-acetaminophen abuse. J Otolaryngol Head Neck Surg 2008; 37: E161-E162
    PubMedGoogle Scholar
  • 46 Rawool V, Dluhy C. Auditory sensitivity in opiate addicts with and without a history of noise exposure. Noise Health 2011; 13: 356-363
    CrossrefPubMedGoogle Scholar
  • 47 Ishiyama A, Ishiyama G, Baloh RW, Evans CJ. Heroin-induced reversible profound deafness and vestibular dysfunction. Addiction 2001; 96: 1363-1364
    PubMedGoogle Scholar
  • 48 Kortequee S, Agada FO, Coatesworth AP. Sudden sensorineural hearing loss following intracarotid injection of heroin. Int J Clin Pract Suppl 2005; 147: 128-129
    PubMedGoogle Scholar
  • 49 Mulch G, Handrock M. [“Sudden binaural deafness” after acute heroin intoxication (author's transl)]. Laryngol Rhinol Otol (Stuttg) 1979; 58: 435-437
    PubMedGoogle Scholar
  • 50 Polpathapee S, Tuchinda P, Chiwapong S. Sensorineural hearing loss in a heroin addict. J Med Assoc Thai 1984; 67: 57-60
    PubMedGoogle Scholar
  • 51 Schrock A, Jakob M, Wirz S, Bootz F. Sudden sensorineural hearing loss after heroin injection. Eur Arch Otorhinolaryngol 2008; 265: 603-606
    CrossrefPubMedGoogle Scholar
  • 52 Stenner M, Stürmer K, Beutner D, Klussmann JP. Sudden bilateral sensorineural hearing loss after intravenous cocaine injection: a case report and review of the literature. Laryngoscope 2009; 119: 2441-2443
    CrossrefPubMedGoogle Scholar
  • 53 Antonopoulos S, Balatsouras DG, Kanakaki S, Done A, Spiliopoulou C, Giannoulois G. Bilateral sudden sensorineural hearing loss caused by alcohol abuse and heroin sniffing. Auris Nasus Larynx 2012; 39: 305-309
    CrossrefPubMedGoogle Scholar
  • 54 Fowler CG, King JL. Sudden bilateral sensorineural hearing loss following speedballing. J Am Acad Audiol 2008; 19: 461-464
    Article in Thieme ConnectPubMedGoogle Scholar
  • 55 Schweitzer VG, Darrat I, Stach BA, Gray E. Sudden bilateral sensorineural hearing loss following polysubstance narcotic overdose. J Am Acad Audiol 2011; 22: 208-214
    Article in Thieme ConnectPubMedGoogle Scholar
  • 56 Grimmer I, Bührer C, Aust G, Obladen M. Hearing in newborn infants of opiate-addicted mothers. Eur J Pediatr 1999; 158: 653-657
    CrossrefPubMedGoogle Scholar
  • 57 van Gaalen FA, Compier EA, Fogteloo AJ. Sudden hearing loss after a methadone overdose. Eur Arch Otorhinolaryngol 2009; 266: 773-774
    CrossrefPubMedGoogle Scholar
  • 58 Christenson BJ, Marjala AR. Two cases of sudden sensorineural hearing loss after methadone overdose. Ann Pharmacother 2010; 44: 207-210
    CrossrefPubMedGoogle Scholar
  • 59 Lupin AJ, Harley CH. Letter: Inner ear damage related to propoxyphene ingestion. Can Med Assoc J 1976; 114: 596
    PubMedGoogle Scholar
  • 60 Harell M, Shea JJ, Emmett JR. Total deafness with chronic propoxyphene abuse. Laryngoscope 1978; 88 (9 Pt 1) 1518-1521
    PubMedGoogle Scholar
  • 61 Ramsay BC. Complete nerve deafness after abuse of co-proxamol. Lancet 1991; 338: 446-447
    PubMedGoogle Scholar
  • 62 Iqbal N. Recoverable hearing loss with amphetamines and other drugs. J Psychoactive Drugs 2004; 36: 285-288
    CrossrefPubMedGoogle Scholar
  • 63 Iqbal N. Hearing loss in amphetamine users. J Psychoactive Drugs 2002; 34: 401-407
    CrossrefPubMedGoogle Scholar
  • 64 Polpathapee S, Tuchinda P, Chiwapong S. Sensorineural hearing loss in a heroin addict. J Med Assoc Thai 1984; 67: 57-60
    PubMedGoogle Scholar
  • 65 Ciorba A, Bovo R, Prosser S, Martini A. Considerations on the physiopathological mechanism of inner ear damage induced by intravenous cocaine abuse: cues from a case report. Auris Nasus Larynx 2009; 36: 213-217
    CrossrefPubMedGoogle Scholar
  • 66 Nicoucar K, Sakbani K, Vukanovic S, Guyot JP. Intralabyrinthine haemorrhage following cocaine consumption. Acta Otolaryngol 2005; 125: 899-901
    CrossrefPubMedGoogle Scholar